Dr. Niyati Narsana, MD

Dr. Narsana practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Narsana's NPI, 1578906723, was assigned on April 8, 2013. Dr. Narsana graduated from B.J. Medical College - University of Pune in 2011. Dr. Narsana holds California license A172652.

Dr. Narsana's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Narsana's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Narsana is also affiliated with Tisch Hospital. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Narsana to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Narsana practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Narsana's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Narsana is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Narsana's licenses on file in 4 states: California, North Carolina, Maryland and District of Columbia.

Dmand AI lists acute skin infection, hiv/aids, immune deficiency disease, joint or bone infection, pneumonia and UTI among the conditions Dr. Narsana treats.

CMS data shows 595 Medicare services from Dr. Narsana across 7 procedure codes in 2024, for 256 Medicare patients. Medicare paid $40,930 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 256 Medicare patients who saw Dr. Narsana in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 4.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Narsana's median patient age at 60, with 43% women.

In 2024, Dr. Narsana wrote 263 Medicare Part D claims for 67 patients. 86% of them were for generic drugs. CMS names the drug for 139 of them, across 7 drugs with 11 or more claims each, at $12,556 in total drug cost. In 2023, CMS named 125 claims across 8 drugs.

Dr. Narsana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Narsana as offering telehealth.

Dmand AI links 6 papers to Dr. Narsana, published from 2016 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Immunocompromised Host and Transplant Recipients. Dr. Narsana has published most often in Transpl Infect Dis. Dr. Narsana's most frequent co-authors are Dora Yukwai Ho, MD, Antonette Ajayi, MD and Muna A. Alnimri, MD.

Dmand AI links Dr. Narsana to 1 clinical trial. Conditions studied include Pneumovirus Infections and Respiratory Syncytial Virus Infections.

Dr. Narsana graduated from B.J. Medical College - University of Pune in 2011.

Dr. Narsana is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.